Cargando…

Mediating Effect of Mutuality on Health-Related Quality of Life in Patients with Parkinson's Disease

The relationship quality, mutuality, has been identified as a protective factor in family care situations, but its role in mediating health-related quality of life (HRQoL) in patients having Parkinson's disease (PD) is not known. Data on patients' and partners' mutuality (MS), motor s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlstedt, Michaela, Fereshtehnejad, Seyed-Mohammad, Aarsland, Dag, Lökk, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164202/ https://www.ncbi.nlm.nih.gov/pubmed/30305888 http://dx.doi.org/10.1155/2018/9548681

Ejemplares similares

Determinants of Dyadic Relationship and Its Psychosocial Impact in Patients with Parkinson's Disease and Their Spouses
por: Karlstedt, Michaela, et al.
Publicado: (2017)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson’s disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2013)

Orthostatic Hypotension in Patients with Parkinson's Disease and Atypical Parkinsonism
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Active Aging for Individuals with Parkinson's Disease: Definitions, Literature Review, and Models
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Psychometric study of the Persian short-form eight-item Parkinson’s disease questionnaire (PDQ-8) to evaluate health related quality of life (HRQoL)
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson's Disease: Longitudinal Data from the Jönköping Parkinson Registry
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2017)

Comparison of the Psychological Symptoms and Disease-Specific Quality of Life between Early- and Typical-Onset Parkinson's Disease Patients
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Motor, Psychiatric and Fatigue Features Associated with Nutritional Status and Its Effects on Quality of Life in Parkinson’s Disease Patients
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
por: Farhadi, Farzaneh, et al.
Publicado: (2017)

Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson’s Disease
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2015)

Reliability and Validity of the Persian Version of the Fatigue Severity Scale in Idiopathic Parkinson's Disease Patients
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2013)

Mortality in Iranian Patients with Parkinson's Disease: Cumulative Impact of Cardiovascular Comorbidities as One Major Risk Factor
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2015)

Cross-Cultural Validity, Reliability, and Psychometric Properties of the Persian Version of the Scales for Outcomes in Parkinson's Disease-Psychosocial Questionnaire
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2015)

Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar, Örjan, et al.
Publicado: (2012)

Comorbidity profile in dementia with Lewy bodies versus Alzheimer’s disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Parkinson’s disease permanent care unit: managing the chronic-palliative interface
por: Lökk, Johan
Publicado: (2011)

Clinical aspects of palliative care in advanced Parkinson’s disease
por: Lokk, Johan, et al.
Publicado: (2012)

Pain management in patients with Parkinson’s disease: challenges and solutions
por: Skogar, Orjan, et al.
Publicado: (2016)

Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Lökk, Johan
Publicado: (2010)

Prevalence and associated comorbidities of restless legs syndrome (RLS): Data from a large population-based door-to-door survey on 19176 adults in Tehran, Iran
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2017)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
por: Green, Holly, et al.
Publicado: (2019)

Editorial: Managing Parkinson's Disease With a Multidisciplinary Perspective
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2021)

Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017)

Lack of information and access to advanced treatment for Parkinson’s disease patients
por: Lökk, J
Publicado: (2011)

Health-Related Quality of Life for Parkinson’s Disease Patients and Their Caregivers
por: Lubomski, Michal, et al.
Publicado: (2021)

Oral health‐related quality of life in patients with Parkinson’s disease
por: Verhoeff, Merel C., et al.
Publicado: (2022)

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
por: Dave, Sonali, et al.
Publicado: (2019)

Cognitive Interventions in Parkinson’s Disease: Where We Want to Go within 20 Years
por: Kalbe, Elke, et al.
Publicado: (2018)

Willingness to pay for a new drug delivery in Parkinson patients
por: Lökk, Johan, et al.
Publicado: (2014)

Association between Mutuality and Health-Related Quality of Life in Patient–Caregiver Dyads Living with Schizophrenia
por: Hsiao, Chiu-Yueh, et al.
Publicado: (2021)

National surveys: a way to manage treatment strategies in Parkinson’s disease? Pharmaceutical prescribing patterns and patient experiences of symptom control and their impact on disease
por: Skogar, Örjan, et al.
Publicado: (2013)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Comparing Clinical Profiles in Alzheimer's Disease and Parkinson's Disease Dementia
por: Farlow, Martin R., et al.
Publicado: (2013)

Predictors of health-related quality of life in Parkinson’s disease: the impact of overlap between health-related quality of life and clinical measures
por: Sanchez-Luengos, Itsasne, et al.
Publicado: (2022)

Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
por: Rektorova, Irena, et al.
Publicado: (2014)

Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative Disorders
por: Pedersen, Camilla Christina, et al.
Publicado: (2023)

Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease
por: Zeighami, Yashar, et al.
Publicado: (2019)

Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity
por: Abbasi, Nooshin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lfde6tnc30vokdkmsjlk9uc1ks